MORDOR II Burkina Faso: Longitudinal Trial (GAMIN)
Gut and Azithromycin Mechanisms in Infants and Neonates
Sponsor: Bill and Melinda Gates Foundation
Listed as NCT03676751, this PHASE4 trial focuses on Child Growth and Child Mortality and remains completed. Sponsored by Bill and Melinda Gates Foundation, it has been updated 15 times since 2019, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE4
-
Apr 2022 — Sep 2023 [monthly]
Completed PHASE4
-
Apr 2021 — Apr 2022 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
▶ Show 10 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE4
-
Aug 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE4
-
Apr 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Nov 2019 — Apr 2020 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2019 — Oct 2019 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE4
-
Apr 2019 — Jun 2019 [monthly]
Not Yet Recruiting PHASE4
-
Nov 2018 — Apr 2019 [monthly]
Not Yet Recruiting PHASE4
-
Oct 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Bill and Melinda Gates Foundation
- Centre de Recherche en Sante de Nouna, Burkina Faso
- University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .